# Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure

> **NCT00988806** · PHASE4 · UNKNOWN · sponsor: **Hospital Universitario de Canarias** · enrollment: 213 (estimated)

## Conditions studied

- Advanced Heart Failure

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00988806
- **Lead sponsor:** Hospital Universitario de Canarias
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 213 (ESTIMATED)
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00988806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00988806, "Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00988806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*